Kemal Malik insider trades

Open-market stock purchases and sales by Kemal Malik, Director at Cartesian Therapeutics, Inc, from SEC Form 4 filings since Jan 2, 2020.

Recent trades

DateStockTradeValue
Jan 2, 2026RNAC Cartesian Therapeutics, IncBought (not open market)—
Jan 2, 2026RNAC Cartesian Therapeutics, IncBought (not open market)—

Companies traded

  • RNAC Cartesian Therapeutics, Inc: other filings, last Jan 2, 2026
  • XLRN Acceleron Pharma Inc: other filings, last Nov 19, 2021

Get free alerts when Kemal Malik files a new trade →